Vaxxinova US, Inc.

Vaxxinova US develops, manufactures, and sells veterinary biologics and customized vaccines to support food-animal health. Its offerings include licensed and autogenous (custom) vaccines, Newport Laboratories whole-cell bacterins and viral vaccines, and products using proprietary SRP technology. The company supports vaccination with molecular diagnostics and laboratory services, helping veterinarians and producers identify relevant pathogens and target prevention programs for cattle, poultry, and swine.